
Starting around a man's mid-30s, total testosterone generally declines at a rate of approximately 10 percent each decade. And as many as 20–30% of men over the age of 45 years have symptoms of low testosterone.
Low testosterone, or testosterone deficiency, occurs when testosterone levels are below the expected range and are accompanied by compatible symptoms or clinical findings. Testosterone influences sexual function, muscle mass, bone density, body composition, sense of wellbeing, motivation, libido, and other physiologic processes.
Evaluating testosterone status requires more than a single testosterone measurement. A thorough assessment includes comprehensive hormone testing - including total and free testosterone - alongside careful evaluation of symptoms consistent with testosterone deficiency, such as changes in libido and sexual function, energy, mood and motivation, muscle mass and body composition, and cognitive function. These findings are interpreted within the context of a patient's broader health, including metabolic health, medications, sleep, and other factors that can influence testosterone levels and symptoms.
Common risk factors and contributors include:
Symptoms vary and are not specific to testosterone deficiency, which is why laboratory testing and clinical evaluation matter. Men with low testosterone may experience:
Testosterone influences sexual function at both the brain and penile-tissue level. It supports sexual desire and helps regulate the signaling involved in translating sexual stimulation into an erectile response.
Testosterone receptors are present in the corpora cavernosa, the erectile chambers of the penis. Testosterone contributes to chemical signaling, smooth-muscle health, and the vascular processes required for the penis to relax, fill with blood, and maintain an erection. Low testosterone can therefore contribute to reduced libido, weaker erections, fewer spontaneous or morning erections, and reduced responsiveness to sexual stimulation.
Testosterone is only one component of erectile function. Vascular health, cardiovascular disease, metabolic health, medications, neurologic factors, pelvic floor function, and psychological factors may also contribute to ED. For that reason, erectile dysfunction should be evaluated in the context of the patient's broader health rather than attributed to testosterone alone.
For appropriately selected men, potential benefits may include:
Response varies by patient, and testosterone therapy is most effective when it is used to treat a documented deficiency rather than nonspecific symptoms alone.
For appropriately selected men with confirmed testosterone deficiency, the contemporary evidence on testosterone replacement therapy is reassuring. Earlier concerns that TRT substantially increased cardiovascular or prostate cancer risk have not been supported by more recent, higher-quality studies.
The largest randomized cardiovascular safety trial to date, TRAVERSE, followed more than 5,200 men with hypogonadism who already had cardiovascular disease or were at high cardiovascular risk. Major cardiovascular events occurred at essentially the same rate in men receiving testosterone and placebo - 7.0% versus 7.3% - demonstrating no increased risk of major adverse cardiovascular events with appropriately prescribed TRT during the study period. Longer observational studies have also followed men receiving testosterone for as long as 10 years without demonstrating a signal of increased cardiovascular risk.
The prostate data are similarly reassuring. In a prostate-safety analysis involving more than 5,200 men, high-grade prostate cancer occurred in 0.19% of men receiving TRT and 0.12% receiving placebo, a difference that was not statistically significant. Rates of overall prostate cancer, prostate biopsy, acute urinary retention, and invasive prostate procedures were also not significantly different between groups. Longer-term registry studies likewise have not demonstrated an increased incidence of prostate cancer among men receiving testosterone therapy.
Testosterone therapy still requires thoughtful patient selection and ongoing monitoring. TRT can increase hematocrit, suppress sperm production and fertility, and may not be appropriate for men with certain cardiovascular or metabolic issues, prostate cancer, or other medical conditions.
TRT is generally considered for men who have symptoms consistent with testosterone deficiency together with measured low testosterone levels. A comprehensive evaluation including both lab results, symptom evaluation, and a discussion of individual risks and side effects help a physician and patient decide whether TRT is appropriate.
Evaluation may include repeat morning testosterone testing, assessment of free testosterone and Luteinizing hormone when appropriate, review of medications and health conditions, and additional laboratory testing to understand why testosterone is low and whether treatment is appropriate.
Testosterone can be effectively delivered in several forms. The best option generally depends on the patient's preferences and lifestyle.
A commonly selected option that offers flexible, easily adjusted dosing and reliable absorption. Patients can be taught to self-administer injections at home, typically once or twice weekly, either subcutaneously or intramuscularly. Dosing frequency can be individualized to help maintain more consistent testosterone levels and minimize fluctuations.
Available as a cream or gel applied to the skin daily and absorbed transdermally. Topical testosterone is non-invasive and can provide consistent daily hormone levels, but absorption can vary and care must be taken to prevent transfer to partners or children through skin contact.
Small pellets implanted under the skin that release testosterone over an extended period. They provide convenience and last between 4–6 months; however, dose adjustments are not possible after the pellet is placed. Pellet insertions are also considered more invasive than injections or cream. Following pellet insertion, the site can be tender for 6–10 days.
Newer formulations, including Jatenzo® and Kyzatrex®, offer a convenient, needle-free option for testosterone replacement. Oral testosterone avoids injections and topical transfer, but requires daily dosing and may increase blood pressure or have higher out-of-pocket costs.
We check in within 8–12 weeks of starting testosterone therapy, then generally every three months as treatment is established. Regular bloodwork - including testosterone levels, PSA, and hematocrit - along with your symptoms, response, and feedback guides dosing and ongoing adjustments.
Testosterone therapy is also managed within the context of your broader health. Our patients undergo proactive cardiovascular, metabolic, and general health screening as part of their ongoing care.
Performance Men's Health provides physician-led testosterone replacement therapy for men in Bellevue, Seattle, and throughout the Puget Sound region. Treatment is guided by comprehensive testing, clinical response, and ongoing monitoring - with a focus on both symptom improvement and long-term health.
Other Treatments
Explore more of what we offer.
Frequently Asked Questions
There is no single testosterone level that determines whether a man should start TRT. The American Urological Association uses a total testosterone level below 300 ng/dL as a reasonable threshold for low testosterone, while reference ranges and diagnostic criteria can vary somewhat between laboratories and medical organizations.
Treatment decisions consider more than total testosterone alone. Symptoms, repeat morning testosterone measurements, and - in appropriate cases - free testosterone are considered alongside age, overall health, fertility concerns, and the potential risks, benefits, and alternatives to treatment.
The goal is to determine whether a patient has clinically meaningful testosterone deficiency and whether testosterone therapy is an appropriate treatment - not simply to treat a laboratory number.
Low testosterone can affect sexual function, energy, mood, strength, muscle mass, body composition, and overall sense of well-being. Some men notice reduced libido or fewer spontaneous erections, while others experience fatigue, decreased motivation, difficulty maintaining muscle, or changes in mood and concentration.
These symptoms are not specific to low testosterone and can have many causes. Determining whether testosterone replacement therapy (TRT) is appropriate requires looking at symptoms alongside total and free testosterone levels and the broader clinical context, including age, overall health, medications, and fertility goals. Treatment decisions should be based on the full clinical picture rather than a single testosterone level.
Some symptoms, particularly libido and energy, may begin to improve within weeks, while changes in body composition, muscle mass, and bone density generally take longer.
Yes, particularly when low testosterone is contributing to erectile dysfunction. Testosterone plays an important role in sexual desire, arousal, nitric oxide signaling, and the vascular and erectile tissue function necessary for healthy erections. When testosterone is low, restoring it to an appropriate range may improve libido, erectile function, and response to other ED treatments.
Testosterone therapy is not a cure for every cause of erectile dysfunction. ED is often multifactorial, and vascular disease, medications, metabolic health, or other factors may also play a role. But maintaining adequate testosterone is an important foundation for healthy sexual and erectile function.
Improved sexual desire is one of the better-established benefits of TRT in men with documented testosterone deficiency.
TRT can increase lean body mass in men with testosterone deficiency, particularly when combined with appropriate resistance training, nutrition, and metabolic health strategies.
Current evidence does not support the older assumption that appropriately prescribed TRT causes prostate cancer, but prostate health should still be assessed and monitored based on age and individual risk. If a patient has active prostate cancer, TRT is contraindicated.
Current high-quality evidence is reassuring regarding the cardiovascular safety of testosterone therapy when it is appropriately prescribed and monitored. The large, randomized TRAVERSE trial followed more than 5,000 men with low testosterone who had cardiovascular disease or were at increased cardiovascular risk. Rates of major cardiovascular events - including heart attack, stroke, and cardiovascular death - were similar in men receiving testosterone and those receiving placebo. In 2025, following its review of this evidence, the FDA removed the cardiovascular-risk language from the boxed warning on testosterone products.
Longer-term observational studies have also found NO increase in cardiovascular events among appropriately treated men, with some studies reporting an association between testosterone therapy and lower rates of cardiovascular events and mortality. These studies cannot establish that testosterone itself is protective, but the overall evidence is increasingly reassuring.
Cardiovascular health remains an important part of testosterone treatment. We evaluate cardiovascular risk before treatment and monitor factors such as blood pressure, blood counts, metabolic health, and other cardiovascular risk markers throughout therapy.
Yes. Exogenous testosterone can significantly suppress sperm production and, in some men, reduce sperm counts to very low levels or even zero. This occurs because testosterone therapy suppresses the hormonal signals from the brain that stimulate the testes to produce sperm.
Sperm production can recover after testosterone is discontinued, but recovery may take months or longer and is not guaranteed. In some men, sperm production may not fully return to baseline.
For this reason, younger men and anyone considering future children should likely avoid TRT or seek alternatives with an informed provider. Men with symptoms of low testosterone who want to preserve fertility may have alternative treatment options that can support testosterone production while maintaining sperm production.
Yes. For younger men or men concerned about their fertility who have low testosterone levels or symptoms, there are alternatives to testosterone replacement therapy (TRT). Rather than giving exogenous testosterone - which suppresses sperm production - certain medications can stimulate the body's own testosterone production while helping preserve the hormonal signals necessary for sperm production.
Clomiphene (Clomid), and in some cases enclomiphene, may be used to stimulate the pituitary hormones LH and FSH, which support natural testosterone and sperm production. Other options, including hCG, may also be appropriate depending on a man's hormone levels, symptoms, and fertility goals.
These treatments are not appropriate for every type of testosterone deficiency. We evaluate testosterone levels, LH and FSH, symptoms, age, and current or future fertility goals to determine whether TRT or a fertility-preserving approach makes the most sense.
Not necessarily. However, many causes of testosterone deficiency are persistent, so some men choose to remain on TRT long term because symptoms and low testosterone levels return when treatment is stopped.
TRT suppresses the body's natural testosterone production. After discontinuing treatment, levels can recover, but the timing and degree of recovery vary based on age, duration of treatment, baseline hormone function, and the underlying cause of low testosterone.
Lifestyle changes - including improvements in weight, metabolic health, sleep, and exercise - may improve natural testosterone production in some men. TRT should therefore be viewed as an individualized treatment decision rather than an automatic lifelong commitment.
Monitoring commonly includes free and total testosterone levels, CBC/hematocrit, PSA (prostate), and metabolic panel along with additional testing based on the patient's individual health and treatment plan.
There is no single best delivery method for every patient. Injections, topical therapy, pellets, oral, and other formulations each have advantages and tradeoffs that should be matched to the individual.
Schedule a consultation with the Performance Men's Health team.